Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
J Endocrinol Invest ; 46(12): 2459-2469, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37095269

RESUMO

BACKGROUND: Standard thyroid function parameters reference intervals (RI) are unsuitable during pregnancy, potentially resulting in incongruous treatments that may cause adverse effects on pregnancy outcomes. We aimed at defining trimester-specific TSH, FT4 and FT3 RI, using samples longitudinally collected from healthy Caucasian women. MATERIALS AND METHODS: Blood samples from 150 healthy Caucasian women, who had a physiological gestation and a healthy newborn at term, were collected in each trimester and at around six months post-partum. They showed mild iodine deficiency. After excluding women with overt TSH abnormalities (> 10 mU/L) and/or TPO antibodies, data from 139 pregnant women were analyzed by means of widely used Roche platforms, and TSH, FT4 and FT3 trimester-specific RI were calculated. Post-partum data were available for 55 subjects. RESULTS: Serum TSH RI were 0.34-3.81 mU/L in the first trimester, and changed slightly to 0.68-4.07 U/L and 0.63-4.00 mU/L in the second and third trimester, respectively. Conversely, both FT4 and FT3 concentrations progressively decreased during pregnancy, the median values in the third trimester being 14.8% and 13.2% lower, respectively, than in the first trimester. Thyroid function parameters in the first trimester were similar to those measured after the end of pregnancy. CONCLUSIONS: This study calculates trimester-specific RI for thyroid function parameters in pregnancy, and proposes the reference limits that should be adopted when using Roche platforms in Caucasian women.


Assuntos
Glândula Tireoide , Tiroxina , Recém-Nascido , Gravidez , Feminino , Humanos , Glândula Tireoide/fisiologia , Testes de Função Tireóidea/métodos , Estudos Prospectivos , Gestantes , Tireotropina , Valores de Referência , Primeiro Trimestre da Gravidez , Resultado da Gravidez
2.
Medicina (B Aires) ; 49(1): 43-7, 1989.
Artigo em Espanhol | MEDLINE | ID: mdl-2698437

RESUMO

Eight male tuberculous patients, between 20 and 60 years of age, were given Isoniazid 5 mg/kg and Ketoconazole 200 mg, first one at a time and then associated. Plasma concentrations were measured 0, 2 and 5 hs after taking the drugs. Isoniazid was measured by spectrophotometry and Ketoconazole by the microbiologic method with Candida albicans as test microorganism. When both drugs were given simultaneously Ketoconazole plasma concentration decreased 75% at 2 hs (p less than 0.025) and 85% at 5 hs (p less than 0.05), whereas that of Isoniazid remained unchanged (Table 1). Mean half-life of Isoniazid was 3.9 +/- 1.4 hs in 7 slow acetylators and 1.1 hs in one fast acetylator when given one at a time and 4.4 +/- 1.5 hs when given simultaneously. A similar study was conducted on 11 tuberculous patients who were given Rifampicin 10 mg/kg and Ketoconazole 200 mg, one at a time and concurrently. Rifampicin was measured by high pressure liquid chromatography. When Rifampicin and Ketoconazole were given concurrently plasma concentration of both drugs was reduced: Ketoconazole decreased 85% at 2 hs (p less than 0.025) and 98% at 5 hs (p less than 0.025) whereas Rifampicin decreased 45% at 2 hs (p less than 0.005) and 40% at 5 hs (p less than 0.005) (Table 2). Mean half-life of Rifampicin was 3.5 +/- 0.8 and 4.2 +/- 1.1 hs, respectively, when it was given alone and concurrently. Studies on chemical interactions between Isoniazid and Ketoconazole and between Rifampicin and Ketoconazole yielded negative results.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Isoniazida/sangue , Cetoconazol/sangue , Rifampina/sangue , Tuberculose/metabolismo , Adulto , Ensaios Clínicos como Assunto , Interações Medicamentosas , Quimioterapia Combinada , Humanos , Isoniazida/administração & dosagem , Cetoconazol/administração & dosagem , Masculino , Pessoa de Meia-Idade , Rifampina/administração & dosagem , Tuberculose/tratamento farmacológico
3.
Medicina [B Aires] ; 49(1): 43-7, 1989.
Artigo em Espanhol | BINACIS | ID: bin-51973

RESUMO

Eight male tuberculous patients, between 20 and 60 years of age, were given Isoniazid 5 mg/kg and Ketoconazole 200 mg, first one at a time and then associated. Plasma concentrations were measured 0, 2 and 5 hs after taking the drugs. Isoniazid was measured by spectrophotometry and Ketoconazole by the microbiologic method with Candida albicans as test microorganism. When both drugs were given simultaneously Ketoconazole plasma concentration decreased 75


at 2 hs (p less than 0.025) and 85


at 5 hs (p less than 0.05), whereas that of Isoniazid remained unchanged (Table 1). Mean half-life of Isoniazid was 3.9 +/- 1.4 hs in 7 slow acetylators and 1.1 hs in one fast acetylator when given one at a time and 4.4 +/- 1.5 hs when given simultaneously. A similar study was conducted on 11 tuberculous patients who were given Rifampicin 10 mg/kg and Ketoconazole 200 mg, one at a time and concurrently. Rifampicin was measured by high pressure liquid chromatography. When Rifampicin and Ketoconazole were given concurrently plasma concentration of both drugs was reduced: Ketoconazole decreased 85


at 2 hs (p less than 0.025) and 98


at 5 hs (p less than 0.025) whereas Rifampicin decreased 45


at 2 hs (p less than 0.005) and 40


at 5 hs (p less than 0.005) (Table 2). Mean half-life of Rifampicin was 3.5 +/- 0.8 and 4.2 +/- 1.1 hs, respectively, when it was given alone and concurrently. Studies on chemical interactions between Isoniazid and Ketoconazole and between Rifampicin and Ketoconazole yielded negative results.(ABSTRACT TRUNCATED AT 250 WORDS)

4.
Acta bioquím. clín. latinoam ; 21(3): 345-9, sept. 1987. tab, ilus
Artigo em Espanhol | LILACS | ID: lil-63950

RESUMO

Se determinó el nivel plasmático de plaguicidas organoclorados en personas no expuestas ocupacionalmente a los mismos, para averiguar el grado de impregnación que posee la población general. Se utilizó como metodología analítica la cromatografia en fase gaseosa, empleando no menos de tres columnas para la identificación de cada plaguicida. Se comprobó la presencia de alfa, ß y gama HCH; p,p'-DDT y p-p'-DDE; heptacloro y heptacloro expóxido en las muestras analizadas, correspondiendo al ß HCH el mayor valor medio y, en el 54% de las muestras analizadas que contenían HCH, mayores niveles individuales que las encontradas para los otros dos isómeros. El menor valor medio obtenido correspondió al epóxido del heptacloro


Assuntos
Adulto , Pessoa de Meia-Idade , Humanos , Masculino , Feminino , Exposição Ambiental , Inseticidas Organoclorados/sangue , Resíduos de Praguicidas , Uso de Praguicidas/tendências , Cromatografia Gasosa , DDT/sangue
5.
Acta bioquím. clín. latinoam ; 21(3): 345-9, sept. 1987. Tab, ilus
Artigo em Espanhol | BINACIS | ID: bin-29742

RESUMO

Se determinó el nivel plasmático de plaguicidas organoclorados en personas no expuestas ocupacionalmente a los mismos, para averiguar el grado de impregnación que posee la población general. Se utilizó como metodología analítica la cromatografia en fase gaseosa, empleando no menos de tres columnas para la identificación de cada plaguicida. Se comprobó la presencia de alfa, ß y gama HCH; p,p-DDT y p-p-DDE; heptacloro y heptacloro expóxido en las muestras analizadas, correspondiendo al ß HCH el mayor valor medio y, en el 54% de las muestras analizadas que contenían HCH, mayores niveles individuales que las encontradas para los otros dos isómeros. El menor valor medio obtenido correspondió al epóxido del heptacloro (AU)


Assuntos
Adulto , Pessoa de Meia-Idade , Humanos , Masculino , Feminino , Inseticidas Organoclorados/sangue , Resíduos de Praguicidas , Uso de Praguicidas/tendências , Exposição Ambiental , Cromatografia Gasosa/métodos , DDT/sangue
6.
Artigo em Espanhol | LILACS | ID: lil-46095

RESUMO

Enfermos tuberculosos que tenían entre 60 y 90 años de edad, sin enfermedades asociadas, ni alteraciones hepáticas y renales, recibieron dosis únicas de 300 y 200 mg de Isoniacida y se midieron en ellos las concentraciones plasmáticas a los 0, 90, 180 y 300 minutos de la toma de la droga. Un grupo control, que tenía entre 25 y 50 años de edad, recibió 300 mg de Isoniacida y se midió en ellos la concentración plasmática a los mismos tiempos. En los pacientes de edad avanzada, tanto en los acetiladores lentos como en los rápidos, la dosis de 300 mg produjo picos de concentración similares a los que se observaron con la misma dosis en los pacientes más jóvenes; cuando recibieron 200 mg de Isoniacida los picos de concentración fueron más bajos pero con valores eficaces desde el punto de vista terapéutico. Estos hallazgos sugierem que todos los tuberculosos de edad avanzada deben ser tratados con 200 mg de Isoniacida, pues esta dosis, además de ser eficaz, producirá menos reacciones adversas


Assuntos
Adulto , Pessoa de Meia-Idade , Humanos , Masculino , Isoniazida/uso terapêutico , Tuberculose Pulmonar/tratamento farmacológico , Isoniazida/sangue
7.
Artigo em Espanhol | BINACIS | ID: bin-31222

RESUMO

Enfermos tuberculosos que tenían entre 60 y 90 años de edad, sin enfermedades asociadas, ni alteraciones hepáticas y renales, recibieron dosis únicas de 300 y 200 mg de Isoniacida y se midieron en ellos las concentraciones plasmáticas a los 0, 90, 180 y 300 minutos de la toma de la droga. Un grupo control, que tenía entre 25 y 50 años de edad, recibió 300 mg de Isoniacida y se midió en ellos la concentración plasmática a los mismos tiempos. En los pacientes de edad avanzada, tanto en los acetiladores lentos como en los rápidos, la dosis de 300 mg produjo picos de concentración similares a los que se observaron con la misma dosis en los pacientes más jóvenes; cuando recibieron 200 mg de Isoniacida los picos de concentración fueron más bajos pero con valores eficaces desde el punto de vista terapéutico. Estos hallazgos sugierem que todos los tuberculosos de edad avanzada deben ser tratados con 200 mg de Isoniacida, pues esta dosis, además de ser eficaz, producirá menos reacciones adversas (AU)


Assuntos
Adulto , Pessoa de Meia-Idade , Idoso , Humanos , Masculino , Estudo Comparativo , Tuberculose Pulmonar/tratamento farmacológico , Isoniazida/uso terapêutico , Isoniazida/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...